{"title":"Addressing cognitive impairment in hypertensive patients: Risk factors and clinical implications","authors":"Yetty Morelent , Santi Tri Meilina , Hidayati Azkiya , Elvima Nofrianni , Sumianto , Willa Putri , Dhini Mufti , Aldora Pratama , Ramtia Darma Putri , Erfan Ramadhani","doi":"10.1016/j.jocn.2025.111105","DOIUrl":null,"url":null,"abstract":"<div><div>Cognitive impairment is a major public health challenge, particularly among aging populations with hypertension. The study by Zuo and Yang provides valuable insights into the predictive risk factors for cognitive decline in hypertensive patients, utilizing a model with strong discriminative ability (AUC ROC: 0.802 in training set, 0.756 in test set). This letter highlights seven key risk factors identified in the study: gender, age, education level, poverty income ratio (PIR), depression, vigorous physical activity, and creatinine levels. Men exhibited a higher risk of cognitive impairment than women, likely due to estrogen’s neuroprotective effects. Advancing age and lower education levels were also strong predictors of cognitive decline. Additionally, socioeconomic disparities and depression significantly influenced cognitive health, underscoring the need for integrated mental health and policy interventions. Protective factors, such as vigorous physical activity and lower creatinine levels, emphasize the importance of lifestyle-based strategies. Implementing this predictive model in routine clinical assessments can aid in early detection and personalized intervention. Future research should refine these findings, incorporating genetic predisposition and dietary influences to enhance cognitive health management in hypertensive patients.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"133 ","pages":"Article 111105"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0967586825000773","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Addressing cognitive impairment in hypertensive patients: Risk factors and clinical implications
Cognitive impairment is a major public health challenge, particularly among aging populations with hypertension. The study by Zuo and Yang provides valuable insights into the predictive risk factors for cognitive decline in hypertensive patients, utilizing a model with strong discriminative ability (AUC ROC: 0.802 in training set, 0.756 in test set). This letter highlights seven key risk factors identified in the study: gender, age, education level, poverty income ratio (PIR), depression, vigorous physical activity, and creatinine levels. Men exhibited a higher risk of cognitive impairment than women, likely due to estrogen’s neuroprotective effects. Advancing age and lower education levels were also strong predictors of cognitive decline. Additionally, socioeconomic disparities and depression significantly influenced cognitive health, underscoring the need for integrated mental health and policy interventions. Protective factors, such as vigorous physical activity and lower creatinine levels, emphasize the importance of lifestyle-based strategies. Implementing this predictive model in routine clinical assessments can aid in early detection and personalized intervention. Future research should refine these findings, incorporating genetic predisposition and dietary influences to enhance cognitive health management in hypertensive patients.
期刊介绍:
This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology.
The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.